What Is a Small Molecule Drug?

Ian Quigley calls a small molecule a tiny chemical that can sit in a pill, go inside a cell, and affect how a protein behaves. Small molecules make up most drugs, and pills in a house are almost certainly small molecules. His company is a machine learning small molecule company. It collects massive numbers of small molecules binding to protein targets, uses the measurements to drive machine learning, and pushes small molecule material into partners and toward patients.

Trying to drug something starts with a protein of interest in the body and an attempt to affect its behavior. Antibodies, a common treatment already on the market, are made by cells. They are large molecules, big enough that they have a hard time getting inside cells and a hard time being in a pill. An antibody treatment, or a protein treatment such as a GLP-1 treatment, has to be given by injection. Large molecules can affect proteins that are easy for them to reach. Proteins inside the cell that drive a lot of disease stay quite challenging for large molecules. In a lot of ways, a little tiny chemical is more appealing than a big protein. Small molecules can be in pills, go inside cells, and affect behaviors there.

Life scientists in the 21st century have made pretty good progress predicting and enabling the behaviors of protein-type drugs. Isomorphic, Chai, and Nabla are among the groups of very smart people pushing on antibody problems.